Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wilkinson

Showing results (271-280 of 319) with videos related to

Pageof 32
Sort By:
Hemoglobin|January 1, 1991
Hb Geelong [beta 139(H17)Asn----Asp]P F Como, D R Hocking, G W Swinton, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 20, 1971
The response of normal men and women to changes in their environmental temperatures and ways of lifeR A McCance, H el-Neil, N el-Din, et al.
Regulatory Toxicology and Pharmacology : RTP|December 1, 2015
Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosolsJason W Flora, Naren Meruva, Chorng B Huang, et al.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie|May 20, 2026
A 12-year review of equestrian related injuries at a major trauma centre in South AfricaT Wilkinson-Smith, V Y Kong, D Lee, et al.
Psychotherapy and Psychosomatics|June 29, 2021
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical TrialSamuel T Wilkinson, Taeho Greg Rhee, Jutta Joormann, et al.
Hemoglobin|January 1, 1991
A new unstable and low oxygen affinity hemoglobin variant: Hb Stanmore [beta 111(G13)Val----Ala]P F Como, B R Wylie, R J Trent, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2023
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 studyNaim Zaki, Li Nancy Chen, Rosanne Lane, et al.
JAMA Psychiatry|October 19, 2022
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysisTaeho Greg Rhee, Sung Ryul Shim, Brent P Forester, et al.
Pageof 32

Showing results (271-280 of 319) with videos related to

Sort By:
Pageof 32
Hemoglobin|January 1, 1991
Hb Geelong [beta 139(H17)Asn----Asp]P F Como, D R Hocking, G W Swinton, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 20, 1971
The response of normal men and women to changes in their environmental temperatures and ways of lifeR A McCance, H el-Neil, N el-Din, et al.
Regulatory Toxicology and Pharmacology : RTP|December 1, 2015
Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosolsJason W Flora, Naren Meruva, Chorng B Huang, et al.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie|May 20, 2026
A 12-year review of equestrian related injuries at a major trauma centre in South AfricaT Wilkinson-Smith, V Y Kong, D Lee, et al.
Psychotherapy and Psychosomatics|June 29, 2021
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical TrialSamuel T Wilkinson, Taeho Greg Rhee, Jutta Joormann, et al.
Hemoglobin|January 1, 1991
A new unstable and low oxygen affinity hemoglobin variant: Hb Stanmore [beta 111(G13)Val----Ala]P F Como, B R Wylie, R J Trent, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2023
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 studyNaim Zaki, Li Nancy Chen, Rosanne Lane, et al.
JAMA Psychiatry|October 19, 2022
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysisTaeho Greg Rhee, Sung Ryul Shim, Brent P Forester, et al.
Pageof 32